Literature DB >> 27500244

Conservative Pancreas Graft Preservation at the Extreme.

Jerome Martin Laurence1, Gonzalo Sapisochin2, Markus Selzner2, Andrea Norgate2, Deepali Kumar3, Ian D McGilvary2, Paul D Preig2, Jeffrey Schiff4, Mark S Cattral2.   

Abstract

Because of the value some patients place in remaining insulin-independent after pancreas transplantation, they may be reluctant to undergo graft pancreatectomy, even in the face of extreme complications, such as graft thrombosis and duodenal segment leak. Partly, for this reason, a variety of complex salvage techniques have been described to save the graft in such circumstances. We report a case of a series of extreme complications related to a leak from the duodenal segment after a simultaneous pancreas and kidney transplant. These included infected thrombosis of the inferior vena cava associated with a graft venous thrombosis and a retroperitoneal fistula. The patient retained graft function with insulin independence and repeatedly declined graft pancreatectomy against the advice of the transplant team. Conservative treatment with percutaneous drainage, antibiotics, and anticoagulation was eventually successful. This outcome is unique in our experience and may be instructive to teams caring for pancreas transplant recipients.

Entities:  

Year:  2015        PMID: 27500244      PMCID: PMC4946502          DOI: 10.1097/TXD.0000000000000558

Source DB:  PubMed          Journal:  Transplant Direct        ISSN: 2373-8731


  22 in total

1.  Comparison between duodenal button and duodenal segment in pancreas transplantation.

Authors:  A M D'Alessandro; H W Sollinger; R J Stratta; M Kalayoglu; J D Pirsch; F O Belzer
Journal:  Transplantation       Date:  1989-01       Impact factor: 4.939

2.  Pancreas graft salvage using pancreatico-duodenectomy with enteric drainage.

Authors:  M S Reddy; S A White; B C Jaques; N Torpey; D M Manas
Journal:  Am J Transplant       Date:  2007-10       Impact factor: 8.086

3.  Impact of transplantation on quality of life in patients with diabetes and renal dysfunction.

Authors:  C R Gross; C Limwattananon; B Matthees; J L Zehrer; K Savik
Journal:  Transplantation       Date:  2000-12-27       Impact factor: 4.939

4.  Effects of portal versus systemic venous drainage in kidney-pancreas recipients.

Authors:  X Martin; P Petruzzo; M Dawahra; L C Feitosa Tajra; M Da Silva; L Pibiri; F Chapuis; J M Dubernard; N Lefrançois
Journal:  Transpl Int       Date:  2000       Impact factor: 3.782

5.  Successful surgical salvage of pancreas allografts after complete venous thrombosis.

Authors:  G Ciancio; J F Julian; L Fernandez; J Miller; G W Burke
Journal:  Transplantation       Date:  2000-07-15       Impact factor: 4.939

6.  Pancreas transplant venous thrombosis: role of endovascular interventions for graft salvage.

Authors:  Andrew H Stockland; Darrin L Willingham; Ricardo Paz-Fumagalli; Hani P Grewal; J Mark McKinney; Christopher B Hughes; Eric M Walser
Journal:  Cardiovasc Intervent Radiol       Date:  2009-01-30       Impact factor: 2.740

7.  Technique of simultaneous renal pancreatoduodenal transplantation with urinary drainage of pancreatic secretion.

Authors:  D D Nghiem; R J Corry
Journal:  Am J Surg       Date:  1987-04       Impact factor: 2.565

Review 8.  Quality of life after pancreas transplantation: a review.

Authors:  C R Gross; C Limwattananon; B J Matthees
Journal:  Clin Transplant       Date:  1998-08       Impact factor: 2.863

9.  Pancreatic anastomosis leak 15 years after simultaneous pancreas-kidney transplantation from late-onset allograft cytomegalovirus duodenal ulcers presenting with gross hematuria.

Authors:  Ekamol Tantisattamo; Roland C K Ng; Heath Chung; Manami Okado
Journal:  Hawaii J Med Public Health       Date:  2013-08

10.  Quality of life in simultaneous pancreas-kidney transplant recipients.

Authors:  Pilar Isla Pera; Joaquin Moncho Vasallo; Alberto Torras Rabasa; Federico Oppenheimer Salinas; Laureano Fernández Cruz Pérez; María José Ricart Brulles
Journal:  Clin Transplant       Date:  2009-08-11       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.